A prospective randomized double-blind placebo-controlled clinical trial assessed the safety and efficacy of secretome derived from allogeneic menstrual blood stromal cells as a treatment in patients with severe COVID-19.
[Stem Cell Research & Therapy]
Sorry, but the selected Zotpress account can't be found.
